0001181431-13-059078.txt : 20131114 0001181431-13-059078.hdr.sgml : 20131114 20131114174136 ACCESSION NUMBER: 0001181431-13-059078 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20131114 FILED AS OF DATE: 20131114 DATE AS OF CHANGE: 20131114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Relypsa Inc CENTRAL INDEX KEY: 0001416792 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260893742 BUSINESS ADDRESS: STREET 1: 700 SAGINAW DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-421-9500 MAIL ADDRESS: STREET 1: 700 SAGINAW DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Buysse Jerry M. CENTRAL INDEX KEY: 0001591466 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36184 FILM NUMBER: 131221706 MAIL ADDRESS: STREET 1: C/O RELYPSA, INC. STREET 2: 700 SAGINAW DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 3 1 rrd395065.xml FORM 3 X0206 3 2013-11-14 0 0001416792 Relypsa Inc RLYP 0001591466 Buysse Jerry M. C/O RELYPSA, INC. 700 SAGINAW DRIVE REDWOOD CITY CA 94063 0 1 0 0 See Remarks Common Stock 36046 D Stock Option (right to buy) 2.76 2019-03-10 Common Stock 6104 D Stock Option (right to buy) 4.65 2020-09-28 Common Stock 20072 D Stock Option (right to buy) 3.96 2021-09-13 Common Stock 47674 D Stock Option (right to buy) 3.96 2022-09-27 Common Stock 32969 D Stock Option (right to buy) 7.40 2023-07-23 Common Stock 43603 D Reflects a 1-for-17.2 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement. 100% of the shares subject to the option are fully vested and exercisable. The shares subject to the option are early exercisable. 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2010 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date. The shares subject to the option are early exercisable. 1/48th of the shares subject to the option vest on each monthly anniversary measured from September 1, 2011 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date. The shares subject to the option are early exercisable. 25% of the shares subject to the option vest on the first anniversary measured from September 19, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date. The shares subject to the option are early exercisable. 25% of the shares subject to the option vest on the first anniversary measured from July 24, 2013 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date. Chief Scientific Officer and SVP, Research /s/ Ronald A. Krasnow, as Attorney-in-Fact for Jerry Buysse 2013-11-14 EX-24. 2 rrd355426_402671.htm POWER OF ATTORNEY rrd355426_402671.html 
                               POWER OF ATTORNEY

        Know all by these presents, that the undersigned hereby constitutes and
appoints each of (i) the Chief Executive Officer of Relypsa, Inc., a Delaware
corporation (the "Company"), who is currently John A. Orwin, (ii) the Company's
Chief Financial Officer, who is currently Kristine M. Ball, and (iii) the
Company's General Counsel, who is currently Ronald A. Krasnow, and their
respective successors, signing singly, with full power of substitution, as the
undersigned's true and lawful attorney-in-fact to:

        (1)     execute for and on behalf of the undersigned, in the
                undersigned's capacity as a director of the Company, Forms 3, 4
                and 5 (including amendments thereto) in accordance with Section
                16(a) of the Securities Exchange Act of 1934 and the rules and
                regulations thereunder and a Form ID, Uniform Application for
                Access Codes to File on EDGAR;

        (2)     do and perform any and all acts for and on behalf of the
                undersigned which may be necessary or desirable to complete and
                execute any such Forms 3, 4 or 5 or Form ID and timely file such
                forms (including amendments thereto) and application with the
                United States Securities and Exchange Commission and any stock
                exchange or similar authority; and

        (3)     take any other action of any type whatsoever in connection with
                the foregoing which, in the opinion of such attorney-in-fact,
                may be of benefit to, in the best interest of, or legally
                required by, the undersigned, it being understood that the
                documents executed by such attorney-in-fact on behalf of the
                undersigned pursuant to this Power of Attorney shall be in such
                form and shall contain such terms and conditions as such
                attorney-in-fact may approve in such attorney-in-fact's
                discretion.

        The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934.

        The undersigned agrees that each such attorney-in-fact herein may rely
entirely on information furnished orally or in writing by the undersigned to
such attorney-in-fact. The undersigned also agrees to indemnify and hold
harmless the Company and each such attorney-in-fact against any losses, claims,
damages or liabilities (or actions in these respects) that arise out of or are
based upon any untrue statements or omission of necessary facts in the
information provided by the undersigned to such attorney-in fact for purposes of
executing, acknowledging, delivering or filing Forms 3, 4 or 5 (including
amendments thereto) or Form ID and agrees to reimburse the Company and such
attorney-in-fact for any legal or other expenses reasonably incurred in
connection with investigating or defending against any such loss, claim, damage,
liability or action.

        This Power of Attorney supersedes any power of attorney previously
executed by the undersigned regarding the purposes outlined in the first
paragraph hereof ("Prior Powers of Attorney"), and the authority of the
attorneys-in-fact named in any Prior Powers of Attorney is hereby revoked.

        This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 or 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier (a) revoked by the undersigned in a signed writing delivered to
the foregoing attorneys-in-fact or (b) superseded by a new power of attorney
regarding the purposes outlined in the first paragraph hereof dated as of a
later date.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 4th day of November, 2013.


                                        /s/ Jerry M. Buysse
                                        -------------------------------------
                                        Jerry M. Buysse